PRESS RELEASE published on 04/23/2025 at 07:00, 1 year 6 months ago From Lab to Unicorn: Xlife Sciences AG Portfolio Company VERAXA Biotech AG to merge with Voyager Acquisition Corp. listed on NASDAQ Xlife Sciences AG's portfolio company VERAXA Biotech AG to merge with Voyager Acquisition Corp., valuing VERAXA at USD 1.64 billion. Nasdaq listing planned for Q4 2025 Nasdaq Biopharmaceutical Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF published on 12/23/2024 at 18:40, 1 year 10 months ago Potential Acquisition of FUSE-AI GmbH by Pineapple Power Corporation Acquisition Xlife Sciences FUSE-AI GmbH Pineapple Power Medical AI
BRIEF published on 12/23/2024 at 18:40, 1 year 10 months ago Acquisition potentielle de FUSE-AI GmbH par Pineapple Power Corporation Acquisition FUSE-AI GmbH Sciences De La Vie X La Puissance De L'ananas IA Médicale
PRESS RELEASE published on 12/23/2024 at 18:35, 1 year 10 months ago Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI GmbH by Pineapple Power Corporation PLC at an Expected Valuation of EUR 80-90 million Xlife Sciences AG announces potential acquisition of FUSE-AI GmbH by Pineapple Power Corporation PLC at EUR 80-90 million valuation, marking a significant milestone in medical AI innovation Acquisition Xlife Sciences AG FUSE-AI GmbH Medical AI Pineapple Power Corporation PLC
BRIEF published on 12/19/2024 at 07:05, 1 year 11 months ago Xlife Sciences AG Releases 2023 ESG Report Highlighting Sustainable Innovation Healthcare Technology Environmental Impact Sustainable Innovation ESG Report Responsible Innovation
BRIEF published on 12/19/2024 at 07:05, 1 year 11 months ago Xlife Sciences AG publie son rapport ESG 2023 mettant en avant l'innovation durable Impact Environnemental Technologie De La Santé Innovation Durable Rapport ESG Innovation Responsable
PRESS RELEASE published on 12/19/2024 at 07:00, 1 year 11 months ago Xlife Sciences AG Publishes 2023 ESG Report: A Continued Commitment to Sustainable Innovation Xlife Sciences AG releases 2023 ESG Report, showcasing commitment to sustainable innovation. Report aligns with GRI Standards and emphasizes environmental, social, and governance performance Innovation Sustainability Xlife Sciences AG GRI Standards ESG Report
BRIEF published on 12/16/2024 at 07:05, 1 year 11 months ago Xlife Sciences AG Announces VERAXA Biotech's Planned NASDAQ Listing Nasdaq Listing Cancer Therapies VERAXA Biotech Biopharmaceutical Growth Xlife Sciences Strategy
BRIEF published on 12/16/2024 at 07:05, 1 year 11 months ago Xlife Sciences AG annonce l'introduction en bourse de VERAXA Biotech au NASDAQ Cotation Au Nasdaq Thérapies Contre Le Cancer VERAXA Biotech Croissance Biopharmaceutique Stratégie De Xlife Sciences
PRESS RELEASE published on 12/16/2024 at 07:00, 1 year 11 months ago Xlife Sciences AG Announces the Intended Listing of VERAXA Biotech AG on the NASDAQ Stock Exchange in the 2025 Fiscal Year Xlife Sciences AG announces the intended listing of VERAXA Biotech AG on the NASDAQ Stock Exchange in the 2025 fiscal year, aiming to advance novel cancer therapies and create value for shareholders Shareholders Xlife Sciences AG Cancer Therapies VERAXA Biotech AG NASDAQ Stock Exchange
Published on 11/20/2026 at 15:00, 1 day 19 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 1 day 19 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 20 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 20 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 20 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 10 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 1 day 11 hours ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 1 day 12 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 1 day 13 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 1 day 15 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 1 day 15 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 16 hours ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 1 day 16 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 15 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR